Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FLYWCH family member 2 (FLYWCH2) is a protein-coding gene in humans that encodes a protein containing FLYWCH-type zinc finger domains, which are characterized by distinctive sequence motifs with conserved hydrophobic residues[1][3]. FLYWCH2 is annotated with RNA-binding activity, and its related family members are generally involved in functions such as gene transcription, translation, chromatin modulation, or protein-protein interactions, and may participate in diverse cellular processes[1][3]. FLYWCH2 shares significant homology with FLYWCH1 and is not currently described as a therapeutic target or druggable receptor, enzyme, transporter, or channel[3]. Disease relevance has been reported for FLYWCH2 with regard to Allan-Herndon-Dudley Syndrome, but no direct evidence links it to drug targeting or biomarker status[3]. The FLYWCH domain is typically associated with chromatin and protein interactions, but the precise biological function in humans remains to be clarified[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FLYWCH family member 2 (FLYWCH2).